참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Piperazine, hexahydrate | HCID 120181 | — |
| 반응물 | 1-Desmethyl-7-depyrazine-7-chloro Norfloxacin | HCID 12733879 | — |
| 생성물 | N-Demethyl Norfloxacin Hydrochloride | HCID 12733902 | 40% |
반응 단계
A mixture of 1-methyl-6-fluoro-7-chloro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid 0.85 g (3.3 millimole) and piperazine hexahydrate 10 g (50 millimole) was heated in a sealed tube at 125°-135° C. (inner temperature) for 22 hours. After cooling, the reaction mixture was evaporated under vacuum. The residue was acidified with acetic acid and the insoluble matters were removed by filtration. The filtrate was neutralized with an aqueous solution of caustic soda. The precipitated crystals were collected by filtration, washed with water and dried. The crystals were dissolved in hot diluted hydrochloric acid, reprecipitated with the addition of ethanol, collected by filtration and dried. Recrystallizing the crystals from a mixed solution of water and ethanol, 0.45 g (40%) of 1-methyl-6-fluoro-7-(1-piperazinyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride was obtained. Colorless powders.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US04448962 |
|---|
| 출처 데이터셋 | uspto-grants-1984_05 |
|---|
| ORD ID | ord-1021ab257267405988074038fd4150dc |
|---|
| 출처 메모 | uspto-grants-1984_05 |
|---|